EntreMed Reports 3Q Profit On Lower Costs
Stock quotes in this article:
ENMD
ROCKVILLE, Md. (AP) Development-stage drug maker EntreMed Inc. reported a third-quarter profit Monday on lower costs and expenses.
The company earned $84,914, or zero cents per share, compared with a loss of $3.4 million, or 4 cents per share, during the same period a year prior. Revenue, mainly from royalties, rose 5 percent to $3.7 million from $3.5 million. Research and development expenses were cut in half to $2.3 million during the quarter. The company had just over $10 million in cash and short-term investments as of Sept. 30. Shares of EntreMed fell 15 cents, or 12 percent, to $1.12 in morning trading. The stock has traded between 15 cents and $1.53 over the last 52 weeks.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
77.00
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |
